Granry-D
The Best Way To Control… Diagnose It


Composition : Irbesartan 150mg & Chlorthalidone 12.5mg

Form : Tablets / Pack : 10 x 10's / Type : ALU-ALU

Description : The angiotensin-II–receptor blocker irbesartan is effective in protecting against the progression of nephropathy due to type 2 diabetes. This protection is independent of the reduction in blood pressure it causes- New England J Med 2001; 345:851-860. There is some evidence that irbesartan provides protective cardiovascular effects beyond its antihypertensive action. This is particularly true for its beneficial effects on slowing the progression of early-stage and late-stage renal disease in hypertensive patients with type 2 diabetes and on promoting regression of left ventricular mass in patients with hypertension and left ventricular hypertrophy. Recent research has further highlighted the positive role of irbesartan in preventing recurrence of arrhythmia in patients with persistent atrial fibrillation, when added to classical antiarrhythmic therapy. Finally, some data suggest an additional benefit in cardiac disease, through a reduction in the risk of heart failure episodes, as observed with other angiotensin receptor blockers- Integr Blood Press Control. 2011; 4: 17–26.

View more products with following salts

GRANRY-150
The Best Way To Control… Diagnose It..


Composition : Irbesartan 150mg.

Form : Tablets / Pack : 10 x 10's / Type : ALU-ALU

Description : The angiotensin-II–receptor blocker irbesartan is effective in protecting against the progression of nephropathy due to type 2 diabetes. This protection is independent of the reduction in blood pressure it causes- New England J Med 2001; 345:851-860. There is some evidence that irbesartan provides protective cardiovascular effects beyond its antihypertensive action. This is particularly true for its beneficial effects on slowing the progression of early-stage and late-stage renal disease in hypertensive patients with type 2 diabetes and on promoting regression of left ventricular mass in patients with hypertension and left ventricular hypertrophy. Recent research has further highlighted the positive role of irbesartan in preventing recurrence of arrhythmia in patients with persistent atrial fibrillation, when added to classical antiarrhythmic therapy. Finally, some data suggest an additional benefit in cardiac disease, through a reduction in the risk of heart failure episodes, as observed with other angiotensin receptor blockers- Integr Blood Press Control. 2011; 4: 17–26.

View more products with following salts

Granry-150H
Mild to Moderate Hypertension


Composition : Irbesartan 150mg + Hydrochlorothiazide 12.5mg

Form : Tablets / Pack : 10's / Type : ALU-ALU

Description : Effective therapeutic option in Mild to Moderate hypertension - Drugs ISSN 0012-6667 Coden Drugay. Significantly reduces Mean 24 hrs ADBP & Ambulatory Systolic Blood Pressure & well tolerated - Ren fail 2007;29(7) 843-8 Its safety & Tolerability is Superior to Placebo - Amer, Journal of Card. 23 Feb 1998

View more products with following salts

Granry-CL
Re-think on Hypertension Management


Composition : Cilnidipine 5mg + Irbesartan 150mg

Form : Tablets / Pack : 10’s / Type : ALU-ALU

Description : Cilnidipine signficantly decreased the 24 h blood pressure by 6.5 1.7 mm Hg systolic (mean s.e.mean; P>0.01) and 5.0 1.1 mmHg diastolic (P > 0.01), whereas Cilnidipine did not change heart rate or any indices of power spectral components - Br J Clin Pharmacol. Dec 2000; 50(6): 615-620 There was no correlation between the degree of daytime SBP change and that of daytime PR change after amlodipine treatement (r=-0.08, n.s.) but there was a significant negative correlation between the degree of daytime SBP change and that of day-time PR change after cilnidipine treatment (r=-0.27, p<0.05). N-type calcium channel blockade by Cilnidipine may not cause reflex tachycardia, and may be useful for hypertensive treatment - Hypertens Res. 2005 Dec; 28(12): 1003-8

View more products with following salts

Granry-AM
In Stubborn Hypertension


Composition : Irbesartan 150mg + Chlorthalidone 12.5mg + Amlodipine 5mg

Form : Tablets / Pack : 10’s / Type : ALU-ALU

Description : As typically prescribed, chlorthalidone in older adults was not associated with fewer adverse cardiovascular events or deaths than hydrochlorothiazide - Department of Internal Medicine (Cardiology), St Louis University School of Medicine (J.D.C.), St. Louis. Hypertension is the leading cause of morality, resulting from coronary heart disease and stroke, affects more than 100 million adults in India. If apply the current rate will be a 42% increase in number of deaths by 2030 - Ann Internm Med. 2013; 158(6):477-455

View more products with following salts

Cylndia-Q
Re-think on Hypertension Management


Composition : Cilnidipine 5mg + Irbesartan 150mg + Chlorthalidone 12.5mg

Form : Tablets / Pack : 10's / Type : ALU-ALU

Description : Unlike Amlodipine, Cilnidipine which inhibits L-and N-type calcium channels will be useful for patients with hypertension and cardiovascular discease, diabetes mellitus or renal disease and proves to be a better alternative to existing calcium channel blockers - Int J Basic Clin Pharmacol. 2013; 2(2): 160-164

View more products with following salts

Candosa-CT
The Treatment of heart Failure


Composition : Candesartan 8mg + Chlorthalidone 12.5mg

Form : Tablets / Pack : 10’s / Type : ALU-ALU

Description : The rcommended dose of candesartan in heart failure is 4mg/day with a target dose of 32mg by doubling the dose in 2 2weekly - Cardiology News; Jul, 2005 -The onset is usually within 2-20 weeks of starting therapy. Rarre instance of clincally apparent acute liver injury have been reproted in association withcandesartan therapy - Hepatotoxicity; http/livertox,nih.gov/index.html -Renal vascular resistance and labumin excretion were reduced following treatement with candesartan.Glucose homeostasis and lipid metabolism were not affected by treatmentin patients with type 2 diabetes mellitus. Candesartan is well tolerated and is not associated with cough - Drugs 2002;62(8):1253-87

View more products with following salts

Benyda-CT
Reno- Cardio Protective Calcium Channel Blocker


Composition : Benidipine 4mg + Chlothalidone 12.5mg

Form : Tablets / Pack : 10’s / Type : ALU-ALU

Description : Reno-Protection: -By triple calcium channel blocking activity, dilates Afferent and Efferent arterioles reduces glomerular pressure. -Prevents the progression of Reno parenchymal hpertension and nephropathy by increasing NO fromation in the renal Parenchyma. -Exerts Natriuretic effect. -Benidipine partially inhibits angiotensin II induced upregulation of the mRNAs and shows Ca2 + influx inhibitory activities for aldosterone production. Cardio Pretction -Benidipine attenuates the extent of ischemia through NO-dependent mechanism. -Benidipine reduces left ventricular mass and normalized systemic collagen type degradation abnormalities in essential hypertensive patients with severe LVH. -Benidipine increases in the plasma levels of CGRP in the patients with essential hypertension. -Benidipine hydrochloride decreases oxidative stress."

View more products with following salts